Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
#How Has The Point-Of-Care Molecular Diagnostics Market Growth Evolved From 2024 To 2025, And What’s Ahead?#_x000D_
The market size of point-of-care molecular diagnostics has witnessed significant expansion in the past few years. The value is projected to escalate from $3.55 billion in 2024 to $3.98 billion in 2025, equating to a compound annual growth rate (CAGR) of 12.0%. This substantial growth during the historical phase is primarily owing to the surge in the necessity for quick disease diagnosis, an increase in infectious disease epidemics, growth of telemedicine and remote testing, regulatory backing for point-of-care diagnostics, and the requirement for personalized and precision medicine._x000D_
_x000D_
The market for point-of-care molecular diagnostics is forecast to see robust growth in the forthcoming years. It’s anticipated to reach $6.92 billion by 2029, expanding at a compound annual growth rate (CAGR) of 14.8%. Factors contributing to the growth during the forecast period include the miniaturization of diagnostic devices, larger-scale point-of-care screening for cancers and genetic disorders, tailored molecular diagnoses for different uses, and the incorporation of artificial intelligence and machine learning for data interpretation, as well as the monitoring of emerging infectious diseases. Key trends expected during the forecast period are lab-on-a-chip and microfluidic technologies, digital health advances, smartphone-based diagnostics, readiness for point-of-care covid-19 and other pandemics, predictive diagnostics powered by AI, and testing based on crispr molecular technology._x000D_
_x000D_
#Download a free sample to assess the report’s scope and structure:#_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=7046&type=smp_x000D_
_x000D_
#What Are the Core Market Drivers Propelling Growth in the Point-Of-Care Molecular Diagnostics Industry?#_x000D_
The escalating prevalence of infectious and respiratory illnesses is anticipated to substantially fuel the expansion of the point-of-care molecular diagnostics market. Respiratory infections, triggered by viruses or bacteria, result from microorganisms affecting the respiratory system. These pathogens can be disseminated through actions like coughing, sneezing, or physical contact. The spectrum of treatments for these conditions is broad, encompassing inhalers, oral drugs, intravenous therapies, and point-of-care molecular diagnoses to help patients recover. For instance, data from the Office for National Statistics, a reputed national statistics institute from the UK, reveals a spike in the infection rate in people between 35 to 69 years of age and school-year students aged 12 to 24 years, as of the week ended December 9, 2022. Therefore, the swiftly rising rates of infectious and respiratory ailments and related fatalities will catalyze the growth of the point-of-care-molecular diagnostics market._x000D_
_x000D_
#How Is the Point-Of-Care Molecular Diagnostics Market Segmented?#_x000D_
The point-of-care molecular diagnosticsmarket covered in this report is segmented – _x000D_
_x000D_
1) By Product And Service: Assays And Kits, Instruments And Analyzers, Software And Services_x000D_
2) By Technology: Reverse Transcription – Polymerase Chain Reaction (RT-PCR), In Situ Hybridization, Sequencing_x000D_
3) By Application: Respiratory Diseases, Hospital Acquired Infections (HAIs), Cancer/Oncology, Hepatitis, Hematology_x000D_
4) By End-User: Decentralized Labs, Hospitals, Home Care, Assisted Living Healthcare Facilities_x000D_
_x000D_
Subsegments:_x000D_
1) By Assays And Kits: Nucleic Acid Amplification Tests (NAATs), Rapid Diagnostic Tests, Molecular Detection Kits, Reagents And Consumables_x000D_
2) By Instruments And Analyzers: PCR Machines, Microfluidic Devices, Sequencers, Point-of-Care Analyzers_x000D_
3) By Software And Services: Data Management Software, Cloud-Based Solutions, Technical Support And Maintenance Services, Consultation And Training Services_x000D_
_x000D_
#Request customized data on this market:#_x000D_
https://www.thebusinessresearchcompany.com/customise?id=7046&type=smp_x000D_
_x000D_
#Which Regions Are Driving the Next Phase of the Point-Of-Care Molecular Diagnostics Market Growth?#_x000D_
North America was the largest region in the point-of-care molecular diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point-of-care molecular diagnostics market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa._x000D_
_x000D_
#What Key Market Trends and Innovations Are Shaping the Future of the Point-Of-Care Molecular Diagnostics Industry?#_x000D_
The rise of technology-based innovation is a fundamental trend gaining traction in the point-of-care molecular diagnostics industry. Major players in this market are concentrating on offering high-tech solutions to bolster their market stature. These businesses are adopting cutting-edge technologies and associated services in point-of-care molecular diagnostics, including enzyme-linked immunosorbent assay (ELISA), polymerase chain reaction (PCR), and mass spectrometry (MS), along with situ hybridizations, spectral karyotyping imaging, and DNA microarrays. These technologies are being utilized on POC devices to expedite analysis times and reduce expenditure. For instance, Sensible Diagnostics, a diagnostic firm based in the United States, unveiled a point-of-care PCR system with a 10-minute turnaround time in May 2023. Sensible Diagnostics is leveraging the expertise it gained from Curative’s diagnostics operations during the pandemic, having conducted over two million point-of-care COVID-19 molecular tests, demonstrating the efficacy of its PCR platform, which yields results in just 10 minutes._x000D_
_x000D_
#View the full report here:#_x000D_
_x000D_
#How Is the Point-Of-Care Molecular Diagnostics Market Defined and What Are Its Core Parameters?#_x000D_
Point-of-care (POC) molecular diagnostics refers to tests that detect the presence of specific nucleic acids in a clinical specimen, such as feces, saliva, urine, blood, and tissue. This molecular diagnostic is based on seeing targeted portions of microbial genetic material, DNA or RNA. It is utilized by the healthcare sector to detect emergency usage authorization to diagnose diseases. Point-of-care (POC) molecular diagnostic is used to detection of disease antigens or antibodies in human samples, such as mononucleosis, influenza, and group A streptococcus (GAS)._x000D_
_x000D_
#Purchase the full report and get a swift delivery:#_x000D_
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7046_x000D_
_x000D_
#About The Business Research Company:#_x000D_
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_
_x000D_
#Get in touch with us:#_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas +1 310-496-7795_x000D_
Europe +44 7882 955267_x000D_
Asia & Others +44 7882 955267 & +91 8897263534_x000D_
Email us at info@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model